In addition, as presented in Figure 1E, the fasting plasma glucose, insulin, and GHbA1c levels significantly increased in WD mice compared with the ND group; however, the fasting plasma glucose, insulin, and GHbA1c levels were significantly decreased in the leflunomide-treated group compared to WD group. Here, INS is linked to Wilson disease.